WallStreetZenWallStreetZen

NASDAQ: AFMD
Affimed Nv Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for AFMD

Based on 5 analysts offering 12 month price targets for Affimed Nv.
Min Forecast
$5.00+977.59%
Avg Forecast
$6.20+1,236.21%
Max Forecast
$7.00+1,408.62%

Should I buy or sell AFMD stock?

Based on 5 analysts offering ratings for Affimed Nv.
Strong Buy
Strong Buy
4 analysts 80%
Buy
1 analysts 20%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their AFMD stock forecasts and price targets.

AFMD stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Cantor Fitzgerald
Bottom 11%
11
Strong BuyReiterates$7.00+1,408.62%2023-09-25
Truist Securities
Bottom 6%
6
Strong BuyMaintains$6.00+1,193.10%2023-08-11
HC Wainwright & Co.
Bottom 1%
1
BuyReiterates$5.00+977.59%2023-08-11
Berenberg
Bottom 35%
35
Strong BuyAssumes$6.00+1,193.10%2023-08-08
Wells Fargo
Bottom 1%
1
Strong BuyAssumes$7.00+1,408.62%2023-03-27

1 of 1

Forecast return on equity

Is AFMD forecast to generate an efficient return?
Company
N/A
Industry
0.6%
Market
28.78%

Forecast return on assets

Is AFMD forecast to generate an efficient return on assets?
Company
N/A
Industry
-0.1%

AFMD revenue growth forecast

How is AFMD forecast to perform vs Biotechnology companies and vs the US market?
Company
54.06%
Industry
35.17%
Market
8.14%
AFMD's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
AFMD's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

AFMD vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
AFMD$0.46$6.20+1,236.21%Strong Buy
AVRO$1.56$2.00+28.21%Buy
FIXX$1.18$7.63+546.19%Buy
TLSA$0.66N/AN/A
CLNN$0.53$7.20+1,271.43%Strong Buy
View Top Biotech Stocks

Affimed Nv Stock Forecast FAQ

Is Affimed Nv Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 5 Wall Street analysts covering (NASDAQ: AFMD) stock is to Strong Buy AFMD stock.

Out of 5 analysts, 4 (80%) are recommending AFMD as a Strong Buy, 1 (20%) are recommending AFMD as a Buy, 0 (0%) are recommending AFMD as a Hold, 0 (0%) are recommending AFMD as a Sell, and 0 (0%) are recommending AFMD as a Strong Sell.

If you're new to stock investing, here's how to buy Affimed Nv stock.

What is AFMD's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: AFMD) forecast ROE is N/A, which is considered weak.

What is AFMD's Price Target?

According to 5 Wall Street analysts that have issued a 1 year AFMD price target, the average AFMD price target is $6.20, with the highest AFMD stock price forecast at $7.00 and the lowest AFMD stock price forecast at $5.00.

On average, Wall Street analysts predict that Affimed Nv's share price could reach $6.20 by Sep 25, 2024. The average Affimed Nv stock price prediction forecasts a potential upside of 1,236.21% from the current AFMD share price of $0.46.

What is AFMD's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: AFMD) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of -0.1%.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.